PCV60 INTRODUCTION OF ROSUVASTATIN WILL ENABLE MORE PATIENTS TO ACHIEVE GUIDELINE LDL-C GOALS WITHIN A FIXED BUDGET IN THE UK
Nov 1, 2003, 00:00
10.1016/S1098-3015(10)61704-4
https://www.valueinhealthjournal.com/article/S1098-3015(10)61704-4/fulltext
Title :
PCV60 INTRODUCTION OF ROSUVASTATIN WILL ENABLE MORE PATIENTS TO ACHIEVE GUIDELINE LDL-C GOALS WITHIN A FIXED BUDGET IN THE UK
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)61704-4&doi=10.1016/S1098-3015(10)61704-4
First page :
Section Title :
Open access? :
No
Section Order :
150